Adage Capital Partners Gp, L.L.C. Aclaris Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$59.7 Billion
Q3 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,278,144 shares of ACRS stock, worth $13.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,278,144

Previous 9,627,304 45.18%

Holding current value

$13.3 Million

Previous $13.7 Million 26.64%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$1.41 - $2.13 $6.13 Million - $9.26 Million	-4,349,160 Reduced 45.18%	5,278,144 $10 Million
Q4 2024 Feb 14, 2025	BUY	$1.15 - $4.59 $11.1 Million - $44.2 Million	9,627,304 New	9,627,304 $23.9 Million
Q2 2023 Aug 14, 2023	SELL	$7.89 - $10.64 $1.42 Million - $1.92 Million	-180,000 Reduced 15.25%	1,000,000 $10.4 Million
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $3.39 Million - $8.62 Million	480,000 Added 68.57%	1,180,000 $9.55 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $980,250 - $1.37 Million	75,000 Added 12.0%	700,000 $11 Million
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $2.03 Million - $3.42 Million	200,000 Added 47.06%	625,000 $8.73 Million
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $4.63 Million - $8.51 Million	-474,997 Reduced 52.78%	425,000 $7.33 Million
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $2.15 Million - $3.24 Million	-175,369 Reduced 16.31%	899,997 $13.1 Million
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $12.4 Million - $17.4 Million	-924,634 Reduced 46.23%	1,075,366 $19.4 Million
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $20.5 Million - $35.5 Million	-1,200,000 Reduced 37.5%	2,000,000 $35.1 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $5.57 Million - $26.3 Million	950,000 Added 42.22%	3,200,000 $80.6 Million
Q4 2020 Feb 16, 2021	SELL	$2.65 - $7.61 $662,500 - $1.9 Million	-250,000 Reduced 10.0%	2,250,000 $14.6 Million
Q2 2020 Aug 14, 2020	BUY	$1.04 - $1.73 $520,000 - $865,000	500,000 Added 25.0%	2,500,000 $4.05 Million
Q1 2020 May 15, 2020	BUY	$0.75 - $2.18 $975,000 - $2.83 Million	1,300,000 Added 185.71%	2,000,000 $2.08 Million
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $1.49 Million - $4.94 Million	700,000 New	700,000 $1.53 Million

Others Institutions Holding ACRS

# of Institutions

104

Shares Held

81.7M

Call Options Held

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $168M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Aclaris Therapeutics, Inc. Transaction History